X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Divis Laboratories - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs DIVIS LABORATORIES - Comparison Results

ABBOTT INDIA    Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DIVIS LABORATORIES 
   Change

Established in the year 1990, Divi's Laboratories has been focusing on CRAMS and is an established player in the custom chemical synthesis (CCS) and API/Intermediate segment. Around 50% of Divi's revenues are derived from custom manufacturing for glo... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA DIVIS LABORATORIES ABBOTT INDIA/
DIVIS LABORATORIES
 
P/E (TTM) x 35.2 34.8 101.3% View Chart
P/BV x 10.2 5.6 181.0% View Chart
Dividend Yield % 0.6 0.9 68.3%  

Financials

 ABBOTT INDIA   DIVIS LABORATORIES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-17
DIVIS LABORATORIES
Mar-17
ABBOTT INDIA/
DIVIS LABORATORIES
5-Yr Chart
Click to enlarge
High Rs5,1901,222 424.7%   
Low Rs4,351784 555.0%   
Sales per share (Unadj.) Rs1,382.9153.1 903.3%  
Earnings per share (Unadj.) Rs130.239.9 325.9%  
Cash flow per share (Unadj.) Rs137.944.6 309.3%  
Dividends per share (Unadj.) Rs40.0010.00 400.0%  
Dividend yield (eoy) %0.81.0 84.1%  
Book value per share (Unadj.) Rs652.7201.8 323.4%  
Shares outstanding (eoy) m21.25265.47 8.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.46.6 52.7%   
Avg P/E ratio x36.625.1 145.9%  
P/CF ratio (eoy) x34.622.5 153.8%  
Price / Book Value ratio x7.35.0 147.1%  
Dividend payout %30.725.0 122.7%   
Avg Mkt Cap Rs m101,373266,266 38.1%   
No. of employees `0003.19.7 31.7%   
Total wages/salary Rs m3,4534,687 73.7%   
Avg. sales/employee Rs Th9,531.94,175.0 228.3%   
Avg. wages/employee Rs Th1,119.9481.5 232.6%   
Avg. net profit/employee Rs Th897.31,089.3 82.4%   
INCOME DATA
Net Sales Rs m29,38740,643 72.3%  
Other income Rs m576749 77.0%   
Total revenues Rs m29,96341,392 72.4%   
Gross profit Rs m3,97314,460 27.5%  
Depreciation Rs m1641,233 13.3%   
Interest Rs m2023 90.3%   
Profit before tax Rs m4,36513,953 31.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5983,349 47.7%   
Profit after tax Rs m2,76710,604 26.1%  
Gross profit margin %13.535.6 38.0%  
Effective tax rate %36.624.0 152.6%   
Net profit margin %9.426.1 36.1%  
BALANCE SHEET DATA
Current assets Rs m18,90640,105 47.1%   
Current liabilities Rs m6,2976,595 95.5%   
Net working cap to sales %42.982.5 52.0%  
Current ratio x3.06.1 49.4%  
Inventory Days Days62119 52.5%  
Debtors Days Days2281 26.8%  
Net fixed assets Rs m1,15919,995 5.8%   
Share capital Rs m213531 40.0%   
"Free" reserves Rs m13,65753,043 25.7%   
Net worth Rs m13,86953,574 25.9%   
Long term debt Rs m00-   
Total assets Rs m20,63861,585 33.5%  
Interest coverage x215.0618.4 34.8%   
Debt to equity ratio x00-  
Sales to assets ratio x1.40.7 215.8%   
Return on assets %13.517.3 78.3%  
Return on equity %19.919.8 100.8%  
Return on capital %31.626.1 121.2%  
Exports to sales %00-   
Imports to sales %025.2 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA10,259 0.0%   
Fx inflow Rs m035,384 0.0%   
Fx outflow Rs m010,399 0.0%   
Net fx Rs m024,985 0.0%   
CASH FLOW
From Operations Rs m3,07211,493 26.7%  
From Investments Rs m-1,554-11,372 13.7%  
From Financial Activity Rs m-898-93 964.1%  
Net Cashflow Rs m62128 2,184.9%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 11.8 66.9%  
FIIs % 0.1 19.0 0.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 17.2 99.4%  
Shareholders   18,270 31,796 57.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA  DR. REDDYS LAB  NOVARTIS  FULFORD INDIA  MERCK LTD  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Extends Losses; Pharma Stocks Top Losers(Closing)

After opening the day in red share markets in India witnessed negative trading activity throughout the day, and ended well below the dotted line.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 21, 2018 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 5-YR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS